Paratek/ Zai Lab antibiotic added for reimbursement in China

Jan. 18, 2023 7:19 AM ETParatek Pharmaceuticals, Inc. (PRTK), ZLABBy: Dulan Lokuwithana, SA News Editor



  • Paratek Pharmaceuticals (NASDAQ:PRTK) announced Wednesday that Nuzyra, a broad-spectrum antibiotic for which the company has partnered with Zai Lab Limited (NASDAQ:ZLAB), has been added to National Reimbursement Drug List (NRDL) in China.
  • The decision by the country’s National

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.